CELL AND GENE THERAPY CATAPULT

Body governed by public law

Information

Name

Type

Body governed by public law

Roles

Buyer
ReviewBody

Company Size

Company Number

Incorporation Date

Website

https://ct.catapult.org.uk/

Address

12TH FLOOR TOWER WING,GUY'S HOSPITAL, GREAT MAZE POND

LONDON
SE19RT
United Kingdom

Suppliers

EIRNA Bio Ltd.
SCIQUIP LIMITED
Ernst & Young LLP
EcoOnline UK Limited
AI Digital
Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with CELL AND GENE THERAPY CATAPULT
Sign up free

Open Opportunities

These are contracts by CELL AND GENE THERAPY CATAPULT which are open for your company to bid on. You can find information about the estimated value, closing dates, etc. on the card.

Open

Published 1 week ago

Report Writing and Data Analysis

Report Writing and Data Analysis Description: The ATTC programme is seeking for organisations and/or independent consultants to provide report writing and data analysis services in relation the outputs of milestones within the 7 workstreams of the Phase 2 Delivery plan. The overall aim is to manage the outputs of the work performed under the Programme in an effective and efficient way that promotes quality, unbiased interpretation of milestone results, and excellent communication that fully comprehends the methodologies that will be applied. The requirement for this service has been identified since funding from the NIHR, Innovate UK was provided, and CGT Catapult was tasked with coordinating the network. This requirement has been clearly identified within the delivery plan and approved by all the relevant bodies as key outputs of key milestones. These reports will not only demonstrate the impact of the work that is being carried out under the Phase 2 programme, but it enables for UK-wide distribution and familiarisation of key initiatives thereby pointing back to the overarching programme goal - Expand and embed the ATTC Network as a sustainable model within the NHS/NIHR to enable equitable and timely access to Advanced Therapies trials. The programme will be run across 4 years with the first report targeted for Mar 2025. There will be reports producible annually and reports produced as determined by the timelines of milestones.

£140,000 Bids close: 2 weeks from now

Contracts awarded by CELL AND GENE THERAPY CATAPULT

These are contracts have closed and been awarded by CELL AND GENE THERAPY CATAPULT to a company or companies. Click on the contract to view more detailed information and view the full details about the winning bid/company.

Contacts

[email protected]

View all 3 contacts, free!

CELL AND GENE THERAPY CATAPULT

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Open Opportunities

Report Writing and Data Analysis

Contracts awarded by CELL AND GENE THERAPY CATAPULT

Ribosome profiling of suspension-adapted HEK293 cells producing adeno-associated viruses

Purchase of Multiple Laboratory Equipment from the London Universities Purchasing Consortium (LUPC) Framework Agreement for General Laboratory Equipment and Associated Post Installation Services LAB5061 LU For Edinburgh Direct Award

Purchase of Multiple Laboratory Equipment from Framework agreement General Laboratory Equipment and Associated Post Installation Services LAB5061 LU Lot 11

Training needs analysis of NHS staff involved in the use and delivery of Advanced Therapy Medicinal Products (ATMPs)

Purchase of Incubators and Microscopes

Purchase of BioMat Safety Cabinets and Germicidal UV lamps

Contacts

Statistics (1 Year)